Literature DB >> 24036059

Melatonin attenuates dexamethasone-induced spatial memory impairment and dexamethasone-induced reduction of synaptic protein expressions in the mouse brain.

Walaiporn Tongjaroenbuangam1, Nootchanart Ruksee, Thanutchaporn Mahanam, Piyarat Govitrapong.   

Abstract

Chronic stress or prolonged exposure to high levels of glucocorticoid induces neuropathological alterations, such as dendritic atrophy of hippocampal or cortical neurons. The chronic administration of high doses of dexamethasone (DEX), a synthetic glucocorticoid receptor agonist, impairs long-term memory and motor coordination, reduces body weight and induces mortality in mice. DEX is typically administered clinically for a prolonged period. Therefore, we are interested in studying the mechanism by which chronic DEX administration affects cognitive function. In this study, we attempted to explore whether chronic DEX administration alters the process of memory formation and to determine the mechanism underlying the detrimental effect of DEX. The results showed that mice treated with DEX for 21 consecutive days had significantly impaired spatial memory in the Morris Water Maze task. Mice treated with DEX had prolonged water maze performance latencies and spent less time in the target quadrant compared to the control group. Furthermore, DEX reduced brain-derived neurotrophic factor (BDNF), N-methyl-d-aspartate (NMDA) receptor subunit (NR2A/B), calcium/calmodulin-dependent protein kinase II (CaMKII) in both the prefrontal cortex and hippocampus and synaptophysin in the prefrontal cortex. We also investigated whether melatonin, a hormone synthesized in the pineal gland, could protect against DEX-induced changes in spatial memory and synaptic plasticity. The results showed that mice pretreated with melatonin prior to the DEX treatment had shorter escape latencies and remained in the target quadrant longer compared to the group only treated with DEX. Melatonin significantly prevented a DEX-induced reduction in the expression of NR2A/B, BDNF, CaMKII and synaptophysin. The results from the present study demonstrate that melatonin pretreatment prevents cognitive impairment caused by DEX. However, the precise mechanism by which melatonin affects cognitive function requires further investigation.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BDNF; CaMKII; Dexamethasone; Melatonin; NMDA receptor; Spatial memory; Stress; Synaptophysin

Mesh:

Substances:

Year:  2013        PMID: 24036059     DOI: 10.1016/j.neuint.2013.08.011

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  12 in total

Review 1.  The Functional and Molecular Properties, Physiological Functions, and Pathophysiological Roles of GluN2A in the Central Nervous System.

Authors:  Yongjun Sun; Xiaokun Cheng; Linan Zhang; Jie Hu; You Chen; Liying Zhan; Zibin Gao
Journal:  Mol Neurobiol       Date:  2016-01-21       Impact factor: 5.590

2.  The neuroprotection of repetitive transcranial magnetic stimulation pre-treatment in vascular dementia rats.

Authors:  Fei Wang; Guang-ming Chang; Qian Yu; Xin Geng
Journal:  J Mol Neurosci       Date:  2015-01-14       Impact factor: 3.444

3.  Chronic Melatonin Treatment Prevents Memory Impairment Induced by Chronic Sleep Deprivation.

Authors:  Karem H Alzoubi; Fadia A Mayyas; Omar F Khabour; Fatima M Bani Salama; Farah H Alhashimi; Nizar M Mhaidat
Journal:  Mol Neurobiol       Date:  2015-06-18       Impact factor: 5.590

Review 4.  Toxin-Induced Experimental Models of Learning and Memory Impairment.

Authors:  Sandeep Vasant More; Hemant Kumar; Duk-Yeon Cho; Yo-Sep Yun; Dong-Kug Choi
Journal:  Int J Mol Sci       Date:  2016-09-01       Impact factor: 5.923

5.  IGF-II promotes neuroprotection and neuroplasticity recovery in a long-lasting model of oxidative damage induced by glucocorticoids.

Authors:  E Martín-Montañez; C Millon; F Boraldi; F Garcia-Guirado; C Pedraza; E Lara; L J Santin; J Pavia; M Garcia-Fernandez
Journal:  Redox Biol       Date:  2017-05-26       Impact factor: 11.799

6.  5,6,7,4'-Tetramethoxyflavanone protects against neuronal degeneration induced by dexamethasone by attenuating amyloidogenesis in mice.

Authors:  Kanet Pakdeepak; Ratchanaporn Chokchaisiri; Jiraporn Tocharus; Pranglada Jearjaroen; Chainarong Tocharus; Apichart Suksamrarn
Journal:  EXCLI J       Date:  2020-01-02       Impact factor: 4.068

7.  Inhibitory Effect of Hexahydrocurcumin on Memory Impairment and Amyloidogenesis in Dexamethasone-Treated Mice.

Authors:  Pranglada Jearjaroen; Kanet Pakdeepak; Chainarong Tocharus; Waraluck Chaichompoo; Apichart Suksamrarn; Jiraporn Tocharus
Journal:  Neurotox Res       Date:  2020-08-27       Impact factor: 3.911

Review 8.  Oxidative Dysregulation in Early Life Stress and Posttraumatic Stress Disorder: A Comprehensive Review.

Authors:  Evangelos Karanikas; Nikolaos P Daskalakis; Agorastos Agorastos
Journal:  Brain Sci       Date:  2021-05-29

9.  Formin 2 links neuropsychiatric phenotypes at young age to an increased risk for dementia.

Authors:  Roberto Carlos Agís-Balboa; Paulo S Pinheiro; Nelson Rebola; Cemil Kerimoglu; Eva Benito; Michael Gertig; Sanaz Bahari-Javan; Gaurav Jain; Susanne Burkhardt; Ivana Delalle; Alexander Jatzko; Markus Dettenhofer; Patricia A Zunszain; Andrea Schmitt; Peter Falkai; Julius C Pape; Elisabeth B Binder; Christophe Mulle; Andre Fischer; Farahnaz Sananbenesi
Journal:  EMBO J       Date:  2017-08-02       Impact factor: 11.598

10.  Long-term administration of melatonin attenuates neuroinflammation in the aged mouse brain.

Authors:  Kannika Permpoonputtana; Patlada Tangweerasing; Sujira Mukda; Parichart Boontem; Chutikorn Nopparat; Piyarat Govitrapong
Journal:  EXCLI J       Date:  2018-07-02       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.